Literature DB >> 29446616

New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange.

Loganathan Rangasamy1, Venkatesh Chelvam1,2, Ananda Kumar Kanduluru1, Madduri Srinivasarao1, N Achini Bandara1, Fei You3, Esteban A Orellana4, Andrea L Kasinski4, Philip S Low1.   

Abstract

Although peptides, antibodies/antibody fragments, siRNAs, antisense DNAs, enzymes, and aptamers are all under development as possible therapeutic agents, the breadth of their applications has been severely compromised by their inability to reach intracellular targets. Thus, while macromolecules can often enter cells by receptor-mediated endocytosis, their missions frequently fail due to an inability to escape their entrapping endosomes. In this paper, we describe a general method for promoting release of any biologic material from any entrapping endosome. The strategy relies on the fact that all nascent endosomes contain extracellular (Na+-enriched) medium, but are surrounded by intracellular (K+-enriched) fluid in the cytoplasm. Osmotic swelling and rupture of endosomes will therefore be facilitated if the flow of K+ down its concentration gradient from the cytosol into the endosome can be facilitated without allowing downhill flow of Na+ from the endosome into the cytosol. While any K+ selective ionophore can promote the K+ specific influx, the ideal K+ ionophore will also exchange influxed K+ for an osmotically inactive proton (H+) in order to prevent buildup of an electrical potential that would rapidly halt K+ influx. The only ionophore that catalyzes this exchange of K+ for H+ efficiently is nigericin. We demonstrate here that ligand-targeted delivery of nigericin into endosomes that contain an otherwise impermeable fluorescent dye can augment release of the dye into the cell cytosol via swelling/bursting of the entrapping endosomes. We further show that nigericin-facilitated escape of a folate-targeted luciferase siRNA conjugate from its entrapping endosomes promotes rapid suppression of the intended luciferase reporter gene. Taken together, we propose that ionophore-catalyzed entry of K+ into endosomal compartments can promote the release of otherwise impermeable contents from their encapsulating endosomes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29446616      PMCID: PMC5926190          DOI: 10.1021/acs.bioconjchem.7b00714

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  52 in total

Review 1.  Engineering folate-drug conjugates to target cancer: from chemistry to clinic.

Authors:  Iontcho R Vlahov; Christopher P Leamon
Journal:  Bioconjug Chem       Date:  2012-06-26       Impact factor: 4.774

2.  Photo-acceleration of protein release from endosome in the protein transduction system.

Authors:  Masayuki Matsushita; Hirofumi Noguchi; Yun-Fei Lu; Kazuhito Tomizawa; Hiroyuki Michiue; Sheng-Tian Li; Kenzo Hirose; Susan Bonner-Weir; Hideki Matsui
Journal:  FEBS Lett       Date:  2004-08-13       Impact factor: 4.124

Review 3.  Carbohydrate drugs: current status and development prospect.

Authors:  Yan Zhang; Fengshan Wang
Journal:  Drug Discov Ther       Date:  2015-04

4.  Probing membrane transport mechanisms with inophores.

Authors:  F M Harold; K H Altendorf; H Hirata
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

5.  Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization.

Authors:  P K Selbo; K Sandvig; V Kirveliene; K Berg
Journal:  Biochim Biophys Acta       Date:  2000-07-26

6.  A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages.

Authors:  Wei Xia; Andrew R Hilgenbrink; Eric L Matteson; Michael B Lockwood; Ji-Xin Cheng; Philip S Low
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

Review 7.  Folate-mediated delivery of macromolecular anticancer therapeutic agents.

Authors:  Yingjuan Lu; Philip S Low
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

Review 8.  Folate receptor endocytosis and trafficking.

Authors:  Shefali Sabharanjak; Satyajit Mayor
Journal:  Adv Drug Deliv Rev       Date:  2004-04-29       Impact factor: 15.470

Review 9.  Targeted drug delivery via folate receptors.

Authors:  Xiaobin Zhao; Hong Li; Robert J Lee
Journal:  Expert Opin Drug Deliv       Date:  2008-03       Impact factor: 6.648

Review 10.  Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges.

Authors:  Alfredo Erazo-Oliveras; Nandhini Muthukrishnan; Ryan Baker; Ting-Yi Wang; Jean-Philippe Pellois
Journal:  Pharmaceuticals (Basel)       Date:  2012-11-01
View more
  6 in total

Review 1.  Protein Delivery: If Your GFP (or Other Small Protein) Is in the Cytosol, It Will Also Be in the Nucleus.

Authors:  David C Luther; Taewon Jeon; Ritabrita Goswami; Harini Nagaraj; Dongkap Kim; Yi-Wei Lee; Vincent M Rotello
Journal:  Bioconjug Chem       Date:  2021-04-19       Impact factor: 4.774

2.  Enhancing MicroRNA Activity through Increased Endosomal Release Mediated by Nigericin.

Authors:  Esteban A Orellana; Ahmed M Abdelaal; Loganathan Rangasamy; Srinivasarao Tenneti; Sunghyun Myoung; Philip S Low; Andrea L Kasinski
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-11       Impact factor: 8.886

3.  Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors.

Authors:  Isabelle M S Degors; Cuifeng Wang; Zia Ur Rehman; Inge S Zuhorn
Journal:  Acc Chem Res       Date:  2019-06-25       Impact factor: 22.384

4.  Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme.

Authors:  Lynn N Jena; Lindsey A Bennie; Emma M McErlean; Sreekanth Pentlavalli; Kim Glass; James F Burrows; Vicky L Kett; Niamh E Buckley; Jonathan A Coulter; Nicholas J Dunne; Helen O McCarthy
Journal:  J Nanobiotechnology       Date:  2021-05-04       Impact factor: 10.435

5.  Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases.

Authors:  Ahmed M Abdelaal; Andrea L Kasinski
Journal:  NAR Cancer       Date:  2021-07-20

Review 6.  Engineering Targeting Materials for Therapeutic Cancer Vaccines.

Authors:  Priscilla S Briquez; Sylvie Hauert; Alexandre de Titta; Laura T Gray; Aaron T Alpar; Melody A Swartz; Jeffrey A Hubbell
Journal:  Front Bioeng Biotechnol       Date:  2020-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.